A Single Institution Review Of Efficacy Of Neoadjuvant Chemoradiation With Gemcitabine/Abraxane Compared to FOLFIRINOX in Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Nguy, S. [1 ]
Du, K. L. [1 ]
机构：
[1] NYU Langone Hlth, Dept Radiat Oncol, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3526
引用
收藏
页码：E658 / E659
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant FOLFIRINOX and/or Gemcitabine/Abraxane for Advanced Pancreatic Adenocarcinoma
    Turner, K.
    Narayanan, S.
    Attwood, K.
    Iyer, R.
    Kuvshinoff, B.
    Hochwald, S.
    Kukar, M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S118 - S119
  • [2] Neoadjuvant FOLFIRINOX Improves Progression Free Survival Compared to Gemcitabine/Abraxane in Pancreatic Adenocarcinoma
    Chapman, B. C.
    Gleisner, A.
    Rigg, D.
    Messersmith, W.
    Paniccia, A.
    Meguid, C.
    McCarter, M. D.
    Gajdos, C.
    Schulick, R.
    Edil, B.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S105 - S106
  • [3] Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma
    Chapman, Brandon C.
    Gleisner, Ana
    Rigg, Devin
    Messersmith, Wells
    Paniccia, Alessandro
    Meguid, Cheryl
    Gajdos, Csaba
    McCarter, Martin D.
    Schulick, Richard D.
    Edil, Barish H.
    JOURNAL OF THE PANCREAS, 2018, 19 (02): : 75 - 85
  • [4] Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen
    Yoo, Changhoon
    Kang, Jihoon
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Lee, Sang Soo
    Park, Do Hyun
    Song, Tae Jun
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    Park, Jin-Hong
    Hwang, Dae Wook
    Song, Ki Byung
    Lee, Jae Hoon
    Kim, Song Cheol
    ONCOTARGET, 2017, 8 (28) : 46337 - 46347
  • [5] Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
    Acuna-Villaorduna, Ana
    Shankar, Viswanathan
    Wysota, Michael
    Jirgal, Amanda
    Kabarriti, Rafi
    Bellemare, Sarah
    Goldman, Inessa
    Kaubisch, Andreas
    Aparo, Santiago
    Goel, Sanjay
    Chuy, Jennifer
    CANCER CONTROL, 2022, 29
  • [6] Modified FOLFIRINOX superior to gemcitabine in resected pancreatic ductal adenocarcinoma
    Thoma C.
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 (3) : 140 - 140
  • [7] Neoadjuvant FOLFIRINOX and/or gemcitabine/nabpaclitaxel for advanced pancreatic adenocarcinoma.
    Turner, Keli
    Narayanan, Sumana
    Attwood, Kristopher
    Hochwald, Steven N.
    Iyer, Renuka V.
    Kukar, Moshim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] Neoadjuvant gemcitabine, docetaxel, and capecitabine results in comparable surgical outcomes to modified FOLFIRINOX in patients with pancreatic ductal adenocarcinoma who also receive radiation: A single institution experience
    Wong, Winston
    Jamison, Jacob K. R.
    May, Michael S.
    Michel, Alissa
    Lee, Tristan
    Manrique, David
    Raufi, Alexander
    Pan, Samuel M.
    Safyan, Rachael A.
    Horowitz, David Paul
    Schrope, Beth
    Kluger, Michael
    Kachnic, Lisa A.
    Hu, Jianhua
    Bates, Susan Elaine
    Chabot, John A.
    Manji, Gulam Abbas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [9] Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma
    Tinchon, Christoph
    Hubmann, Eva
    Pichler, Angelika
    Keil, Felix
    Pichler, Martin
    Rabl, Hans
    Uggowitzer, Martin
    Jilek, Kurt
    Leitner, Gerhard
    Bauernhofer, Thomas
    ACTA ONCOLOGICA, 2013, 52 (06) : 1231 - 1234
  • [10] Conditional Survival in Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation
    Sekigami, Yurie
    Michelakos, Theodoros
    Kontos, Filippos
    Qadan, Motaz
    Catalano, Onofrio Antonio
    Deshpande, Vikram
    Lillemoe, Keith D.
    Ferrone, Cristina Rosa
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S155 - S156
12345